U.S. drugmaker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database clinicaltrials.gov.
The phase 1/2 trial, which is based in Belgium, aims to recruit 260 healthy participants to test the experimental vaccine V591, which it gained access to as part of its May deal for Austrian vaccine maker Themis Bioscience.
The vaccine is based on a modified measles virus that delivers bits of the new coronavirus into the body to prevent COVID-19. Merck is late to join the race to develop a safe and effective vaccine for the fast-spreading respiratory illness as rivals Pfizer Inc, AstraZeneca Plc and Moderna Inc are already in late-stage testing.
The drugmaker is also collaborating with research non-profit IAVI on a second vaccine candidate that uses the same technology as Merck’s Ebola vaccine, ERVEBO. Earlier this month, Chief Executive Kenneth Frazier had said the second candidate is likely to begin trials later this year.Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Why AstraZeneca pausing its COVID-19 vaccine trial may be good newsAstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.' The promising vaccine candidate created by researchers at Oxford had been marching through rounds of clinical trials before word
Weiterlesen »
‘I Don’t Want To Scare People:’ Trump Again Defends Downplaying COVID-19More than 190,000 people in the U.S. have died from COVID-19, but the president argued that the number would’ve been far higher without his actions.
Weiterlesen »
Covid-19 Cases, Death Rates Are Declining Six Months Into PandemicThe U.S. is catching its breath after six months of the coronavirus pandemic, with the daily death toll from Covid-19 declining, but public-health authorities are warning Americans not to let their guard down.
Weiterlesen »
Trump Defends Decision To Play Down COVID-19 Before Peak Of PandemicThe president didn't deny telling Bob Woodward he'd downplayed the threat of the coronavirus, saying at a press conference that he 'didn't want to create panic.'
Weiterlesen »